Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaboration.

Cope AP, Barnes MR, Belson A, Binks M, Brockbank S, Bonachela-Capdevila F, Carini C, Fisher BA, Goodyear CS, Emery P, Ehrenstein MR, Gozzard N, Harris R, Hollis S, Keidel S, Levesque M, Lindholm C, McDermott MF, McInnes IB, Mela CM, Parker G, Read S, Pedersen AW, Ponchel F, Porter D, Rao R, Rowe A, Schulze-Knappe P, Sleeman MA, Symmons D, Taylor PC, Tom B, Tsuji W, Verbeeck D, Isaacs JD; RA-MAP Consortium.

Nat Rev Rheumatol. 2018 Jan 24;14(2):119. doi: 10.1038/nrrheum.2018.6.

PMID:
29362468
2.

The RA-MAP Consortium: a working model for academia-industry collaboration.

Cope AP, Barnes MR, Belson A, Binks M, Brockbank S, Bonachela-Capdevila F, Carini C, Fisher BA, Goodyear CS, Emery P, Ehrenstein MR, Gozzard N, Harris R, Hollis S, Keidel S, Levesque M, Lindholm C, McDermott MF, McInnes IB, Mela CM, Parker G, Read S, Pedersen AW, Ponchel F, Porter D, Rao R, Rowe A, Schulz-Knappe P, Sleeman MA, Symmons D, Taylor PC, Tom B, Tsuji W, Verbeeck D, Isaacs JD; RA-MAP Consortium.

Nat Rev Rheumatol. 2018 Jan;14(1):53-60. doi: 10.1038/nrrheum.2017.200. Epub 2017 Dec 7. Review. Erratum in: Nat Rev Rheumatol. 2018 Jan 24;14 (2):119.

3.

Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.

Kremer JM, Blanco R, Halland AM, Brzosko M, Burgos-Vargas R, Mela CM, Rowell L, Fleischmann RM.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):625-33. Epub 2016 Apr 15.

PMID:
27087059
4.

Glucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics Trials.

Boers M, Aletaha D, Mela CM, Baker DG, Smolen JS.

J Rheumatol. 2016 Jun;43(6):1024-6. doi: 10.3899/jrheum.150932. Epub 2016 Apr 1.

PMID:
27036379
5.

Short communication: NKG2C+ NK cells contribute to increases in CD16+CD56- cells in HIV type 1+ individuals with high plasma viral load.

Gregson JN, Kuri-Cervantes L, Mela CM, Gazzard BG, Bower M, Goodier MR.

AIDS Res Hum Retroviruses. 2013 Jan;29(1):84-8. doi: 10.1089/AID.2011.0397. Epub 2012 Sep 25.

6.

Increased proportion of CD16(+) NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment.

Steel AW, Mela CM, Lindsay JO, Gazzard BG, Goodier MR.

Aliment Pharmacol Ther. 2011 Jan;33(1):115-26. doi: 10.1111/j.1365-2036.2010.04499.x. Epub 2010 Oct 29.

7.

Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals.

Mela CM, Steel A, Lindsay J, Gazzard BG, Gotch FM, Goodier MR.

AIDS. 2007 Oct 18;21(16):2177-82.

PMID:
18090044
8.

Immune modulation and reconstitution of HIV-1-specific responses: novel approaches and strategies.

Burton CT, Mela CM, Rosignoli G, Westrop SJ, Gotch FM, Imami N.

Curr Med Chem. 2006;13(26):3203-11. Review.

PMID:
17168707
9.

The contribution of cytomegalovirus to changes in NK cell receptor expression in HIV-1-infected individuals.

Mela CM, Goodier MR.

J Infect Dis. 2007 Jan 1;195(1):158-9; author reply 159-60. No abstract available.

PMID:
17152020
10.

NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma.

Goodier MR, Mela CM, Steel A, Gazzard B, Bower M, Gotch F.

J Virol. 2007 Jan;81(1):430-3. Epub 2006 Oct 11.

11.

Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy.

Mela CM, Burton CT, Imami N, Nelson M, Steel A, Gazzard BG, Gotch FM, Goodier MR.

AIDS. 2005 Nov 4;19(16):1761-9.

PMID:
16227783

Supplemental Content

Support Center